July 24, 2025
Kaiser Permanente research found that breast cancer survivors have a higher risk of developing other cancers if they have other preexisting health conditions, such as high blood pressure and diabetes.
“Preexisting health conditions are common in people diagnosed with cancer and what we’ve learned with this study is that comorbidities — experiencing multiple illnesses or disorders ...
Read more... July 24, 2025
Maheen Humayun, PhD, MPH, is an infectious disease epidemiologist and postdoctoral research fellow in the Department of Research & Evaluation. Prior to joining Kaiser Permanente, Dr. Humayun worked as an HIV Cluster Detection and Response Fellow at the Centers for Disease Control and Prevention. In that role, she analyzed national HIV surveillance data to detect rapid ...
Read more... July 24, 2025
About 16% of breast cancer survivors continued to use opioid pain medications after their cancer treatment was complete, a new Kaiser Permanente study showed. The study also found that risk of death was 84% higher among these survivors who continued to use opioids.
The study was published in June 2025 in JNCI Cancer Spectrum.
“The most important ...
Read more... July 1, 2025
Growing numbers of patients are diagnosed with cancer between the ages of 15 and 39. These younger cancer patients can have complex health needs after their cancer treatment and should receive health care that includes screening for new cancers, addresses potential issues related to their treatment, and emphasizes general preventive care.
Researchers at Kaiser Permanente Southern ...
Read more... June 16, 2025
Young cancer survivors were more likely to be on long-term opioid therapy when compared to their counterparts without cancer. But among those on long-term opioid therapy, young cancer survivors were less likely to develop opioid use disorder than their peers without cancer, according to Kaiser Permanente research.
The study was published in Cancer in May 2025.
“We ...
Read more... June 16, 2025
A novel treatment algorithm developed and implemented within Kaiser Permanente Southern California increased the use of effective medications for people with multiple sclerosis (MS), and reduced treatment disparities for Hispanic and Black patients.
“Studies show Hispanic and Black people with MS typically have higher levels of disability than white people, but no studies have addressed whether ...
Read more... May 20, 2025
Navdeep S. Sangha, MD, is a vascular neurologist and co-assistant chief of Neurology at the Kaiser Permanente Los Angeles Medical Center. He is the director of the Kaiser Permanente Southern California Regional Stroke Program and the Kaiser Permanente Southern California Telestroke Program. He joined Los Angeles Medical Center’s Neurology Department in 2012.
As the principal investigator for ...
Read more... May 12, 2025
*Final in a series highlighting research nurses during Nurses Week 2025*
Michael Fechter, LVN, was an emergency medical technician, working to become a paramedic and firefighter. On one emergency call, a critical care transport nurse suggested something that changed the direction of his career.
“She told me that I needed to be where I could make a ...
Read more...